Nearly 15 years ago when I first presented the results of our systematic review on antibiotics for acute otitis media, one paediatrician snarled, “You’re making it too complicated. It’s simple: […]
Paul Glasziou
Paul Glasziou: From mummified evidence to living EBM—a few tools
On a tour of WHO headquarters, in Geneva, I wandered past a vast cellar of shrink wrapped unused and unread guidelines. It occurred to me that, given around 7% of […]
Paul Glasziou: Can’t buy me love … but can money buy me clinical quality?
When the Beatles claimed that they “don’t care too much for money, money can’t buy me love,” they did not provide scientific references. While we might hope that statements of […]
Paul Glasziou: Most innovations are not advances: innovation + evaluation = progress
Innovation is currently fashionable. But new is not necessarily better [1]. Progress rests in sifting out the effective innovations. Edison clearly understood this process: when he developed the light bulb, […]
Paul Glasziou: Santa, could you take some things away instead?
Dear Santa, This year, instead of presents I wondered if instead you might take some things away? Maybe you could start with unnecessary tests, unhelpful diagnoses, and over treatment? These […]
Paul Glasziou: How many journals do you need to read?
Do you regularly read Chronobiology International? No, me neither. But that was the source journal for the article we read at a recent GP journal club I attended in Perth […]
Paul Glasziou: Should we abandon the term “hypertension?”
Disease labels have an aura of authority and permanence. But definitions can drift considerably over time changing who is and is not classified as “diseased.” For hypertension, Greene [1] has […]